| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/30/2006 | US7052842 Method for highly sensitive hybridization of nucleic acids, and method for gene analysis using the same |
| 05/30/2006 | US7052840 Reversible association of nucleic acid with a carboxylated substrate |
| 05/30/2006 | US7052838 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 05/30/2006 | US7052835 Method of screening a gene |
| 05/30/2006 | US7052703 T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof |
| 05/30/2006 | US7052702 comprises a light-chain or a heavy-chain fragment of a Pseudonomas neurotoxin with a proteolytically active enzyme domain; N-acetylgalactosamine-binding lectins; to inhibit the release of neurotransmitters from neurons thereby reducing and/or preventing transmission of afferent pain signals |
| 05/30/2006 | US7052699 Immunogenic composition |
| 05/30/2006 | US7052694 Immunoglobulin which specifically binds cell surface protein of nervous system tissue for preventing infections and treating tumors; anticarcinogenic agents; bactericides |
| 05/30/2006 | US7052692 increasing transcription via inhibition of D-sequence-binding protein (D-BP), which is phosphorylated at tyrosine residues for blocking Adeno-mediated transgene expression in infected cells; inhibiting protein kinase activity; cancer treatment |
| 05/30/2006 | US7052691 Vascular Endothelial Growth Factors (VEGF) by injection; for decreased serum glucose concentrations, improved glucose tolerance, increased insulin sensitivity, and reduced hyperinsulinemia |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | US7052687 Human recombinant beta-interferon with improved solubility |
| 05/30/2006 | US7052675 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2285450C Regulatory element for expressing genes in plants |
| 05/30/2006 | CA2249627C Method and device for making composite sheets |
| 05/30/2006 | CA2242767C Glycosidase enzymes |
| 05/30/2006 | CA2165971C Methylphosphonic acid ester, process for preparing the same and its use |
| 05/30/2006 | CA2005311C Prototype felv isolates for use in disease models and vaccines |
| 05/29/2006 | CA2526684A1 Therapeutic peptides and method |
| 05/27/2006 | CA2526685A1 Expression cassettes for root-preferential expression in plants |
| 05/26/2006 | WO2006055931A2 Vectors for stable gene expression |
| 05/26/2006 | WO2006055898A2 Orthogonal suppressor trnas and aminoacyl-trna synthetases and uses thereof |
| 05/26/2006 | WO2006055852A1 Methods of developing a stem cell line |
| 05/26/2006 | WO2006055631A2 Casein kinase stress-related polypeptides and methods of use in plants |
| 05/26/2006 | WO2006055487A2 Maize cr1bio gene promoter and its use to direct root-preferred transgene expression in plants |
| 05/26/2006 | WO2006055351A2 Structure-based compound design involving riboswitches |
| 05/26/2006 | WO2006055322A2 High arachidonic acid producing strains of yarrowia lipolytica |
| 05/26/2006 | WO2006055040A2 Identification of proteins in a genome |
| 05/26/2006 | WO2006054997A1 Aspergillus niger promoter for expressing genes in host cells |
| 05/26/2006 | WO2006054961A2 Novel composition and methods for the treatment of immune related diseases |
| 05/26/2006 | WO2006054815A1 Recombinant expression vector for production of plants having multiple stress tolerances, and method for preparing multiple stress-tolerant plants using the same |
| 05/26/2006 | WO2006054807A1 METHOD OF SITE-SPECIFICALLY TRANSFERRING UNNATURAL AMINO ACID INTO PROTEIN WITH THE USE OF MITOCHONDRIAL PROTEIN AND METHOD OF EFFICIENTLY PREPARING tRNA |
| 05/26/2006 | WO2006054806A1 Crohn’s disease-associated autoantigen |
| 05/26/2006 | WO2006054792A1 Springiness and stiffness improving agent for hair and cosmetic preparation for hair |
| 05/26/2006 | WO2006054788A1 METHOD OF SCREENING COMPOUND REGULATING THE TRANSLATION OF SPECIFIC mRNA |
| 05/26/2006 | WO2006054773A1 Activation of caspase in the cell division stage of cancer cells and utilization of caspase inhibitor in anticancer agent and so on |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |
| 05/26/2006 | WO2006054766A1 Method of inducing genome reorganization via intracellular activation of thermostable multifrequency dna-cleaving enzyme |
| 05/26/2006 | WO2006054748A1 Remedy for nephritis |
| 05/26/2006 | WO2006054740A1 Nucleic acid fragments for detecting nucleic acid and method of detecting nucleic acid |
| 05/26/2006 | WO2006054722A1 Method of diagnosing the risk of thermolabile phenotype diseases by using gene |
| 05/26/2006 | WO2006054705A1 Cell-free protein synthesis method with the use of linear template dna and cell extract therefor |
| 05/26/2006 | WO2006054691A1 Soluble protein and utilization of the same |
| 05/26/2006 | WO2006054690A1 Method of detecting gene polymorphism, method of diagnosing, apparatus therefor and test reagent kit |
| 05/26/2006 | WO2006054683A1 Method of detecting antibody with the use of cell-free protein synthesis system and method of screening specific protein |
| 05/26/2006 | WO2006054666A1 Chick lif protein and utilization thereof |
| 05/26/2006 | WO2006054625A1 Cancer-cell-specific cytostatic agent |
| 05/26/2006 | WO2006054600A1 Novel protein and preventive/remedy for neurodegenerative disease such as polyglutamine disease using the same |
| 05/26/2006 | WO2006054595A1 Novel high alkaline protease and use thereof |
| 05/26/2006 | WO2006054561A1 Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant |
| 05/26/2006 | WO2006054557A1 Cell-free protein synthesis system for synthesizing glycoprotein |
| 05/26/2006 | WO2006054556A1 Cell-free protein synthesis system originating in cultured mammalian cells |
| 05/26/2006 | WO2006054500A1 Gene encoding methylated catechin synthase |
| 05/26/2006 | WO2006054492A1 Method of amplifying target gene contained in biological sample |
| 05/26/2006 | WO2006054474A1 Dextrin dextranase, method of producing the same and use of the same |
| 05/26/2006 | WO2006054458A1 Herbicide-resistance gene and utilization thereof |
| 05/26/2006 | WO2006054371A1 Novel ion channel-like polypeptide and use thereof |
| 05/26/2006 | WO2006054333A1 Truncated sialic acid transferase |
| 05/26/2006 | WO2006054326A2 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity |
| 05/26/2006 | WO2006054297A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 05/26/2006 | WO2006054177A1 Improved treatment of cancer using tlr3 agonists |
| 05/26/2006 | WO2006054129A1 Improved treatment of cancer by double-stranded rna |
| 05/26/2006 | WO2006054096A2 Soluble bifunctional proteins |
| 05/26/2006 | WO2006054059A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | WO2006053929A1 Method of producing the penicillin v acylase enzyme from streptomyces lavendulae in recombinant micro-organisms |
| 05/26/2006 | WO2006053871A2 Multivalent vaccines comprising recombinant viral vectors |
| 05/26/2006 | WO2006053861A1 Oligonucleotides that induce the secretion of gm-csf |
| 05/26/2006 | WO2006053788A2 Alterations in seborrheic keratoses and their applications |
| 05/26/2006 | WO2006053787A1 A non-human animal alzheimer’s disease model and uses thereof |
| 05/26/2006 | WO2006053783A1 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents |
| 05/26/2006 | WO2006053782A1 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents |
| 05/26/2006 | WO2006053743A2 Arabidopsis and brassica nucleic acid sequences conferring lipid and sugar alterations in plants and methods of use |
| 05/26/2006 | WO2006053725A1 Genic variant of the annexin a5 gene |
| 05/26/2006 | WO2006053683A2 Gene silencing using sense dna and antisense rna hybrid constructs coupled to peptides facilitating the uptake into cells |
| 05/26/2006 | WO2006053568A1 Tnf antagonists |
| 05/26/2006 | WO2006053565A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/26/2006 | WO2006053485A1 A chimeric mycobacterium tuberculosis gene vaccine and the preparation method thereof |
| 05/26/2006 | WO2006053473A1 A bacillus thuringiensis and genes with high larvicidal activity to coleopterans |
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006053430A1 Sirna silencing of apolipoprotein b |
| 05/26/2006 | WO2006034061A3 Synthetic nucleic acid molecule and methods of preparation |
| 05/26/2006 | WO2006030126A3 Method of accelerating somatic mutations and use thereof in proteomics |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2006004660A3 Detection of mutations in a gene associated with resistance to viral infection |
| 05/26/2006 | WO2006003298A3 Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same |
| 05/26/2006 | WO2005121370A3 Oligomeric compounds that facilitate risc loading |
| 05/26/2006 | WO2005116658A3 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
| 05/26/2006 | WO2005113817A3 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 05/26/2006 | WO2005112619A3 Novel gene disruptions, compositions and methods relating thereto |
| 05/26/2006 | WO2005111238A3 Aptamer-mediated intracellular delivery of therapeutic oligonucleotides |
| 05/26/2006 | WO2005110067A3 Method and compositions for rna interference |
| 05/26/2006 | WO2005104836A3 Drosophila models for diseases affecting learning and memory |
| 05/26/2006 | WO2005100383A3 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 05/26/2006 | WO2005089812A3 Novel antibiotic alternatives |
| 05/26/2006 | WO2005079533A3 Methods and compositions for mediating gene silencing |
| 05/26/2006 | WO2005069880A3 Modulation of line-1 reverse transcriptase |
| 05/26/2006 | WO2005059149A3 Improved protein production |
| 05/26/2006 | WO2005049787A3 Compositions and methods for in vitro sorting of molecular and cellular libraries |